Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1063-1067

  Watkins, Pamela J ^a   Condreay, J Patrick ^a   Huber, Brian E ^a   Jacobs, Steven J ^a   Adams, David J ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CELL TRANSFORMATION; CLONOGENIC ASSAY; ENHANCER REGION; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; VECTOR CONTROL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0030022255     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Umek, R. M., Friedman, A D., and McKnight, S. L. CCAAT-enhancer binding protein, a component of a differentiation switch. Science (Washington DC). 251: 288-292, 1991.
2. Birkenmeier, E. H., Gwynn, B , Howard, S , Jerry, J., Gordon, J. I., Landschulz, W H , and McKnight, S. L. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein Genes & Dev , 3: 1146-1156, 1989.
3. Friedman, A D , Laadschulz, W H , and McKnight, S L. CCAAT/enhancer binding protein activates, the promoter of the serum albumin gene in cultured hepatoma cells. Genes & Dev., 3: 1314-1322, 1989.
4. Johnson, P. F , Landschulz, W H., Graves, B. J , and McKnight, S. L. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses Genes & Dev., 1: 133-146, 1987
5. Metzger, S., Halaas, J. L., Breslow, J. L., and Sladek, F M. Orphan receptor HNF-4 and bZip protein C/EBPα bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription. J. Biol. Chem., 268. 16831-16838, 1993.
6. Cheneval, D., Christy, R. J., Geiman, D., Cornelius, P., and Lane, M. D. Cell-free transcription directed by the 422 adipose P2 gene promoter: activation by the CCAAT/enhancer binding protein Proc. Natl Acad. Sci. USA, 88: 8465-8469, 1991
7. Kaestner, K. H., Christy, R. J., and Lane, M D. Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein Proc. Natl. Acad Sci. USA, 87: 251-255, 1990.
8. Christy, R. J , Yang, V. W , Niambi, J M., Geiman, D. E., Landschulz, W H , Friedman, A D , Nakabeppu, Y., Kelly, T. J , and Lane, M. D. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes Genes & Dev., 3. 1323-1335, 1989.
9. Lin, F-T., and Lane, M. D. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA, 91: 8757-8761, 1994.
10. Freytag, S O., Paielli, D. L., and Gilbert, J. D. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes & Dev., 8: 1654-1663, 1994.
11. Diehl, A. M., and Yang, S. Q. Regenerative changes in C/EBPα and C/EBPβ expression modulate binding to the C/EBPα site in the c-fos promoter. Hepatology, 19: 447-456, 1994.
12. Freytag, S. O , and Geddes, T J. Reciprocal regulation of adipogenesis by Myc and C/EBP α. Science (Washington DC), 256: 379-382, 1992.
13. Hendricks-Taylor, L. R., Pereira-Smith, O. M., and Darlington, G. J. Growth inhibition of cultured cells by C/EBPα (Abstract) In Vitro Cell. & Dev. Biol., 29A: 104A, 1993.
14. Pereira-Smith, O. M , and Smith, J. R. Genetic analysis of indefinite division in human cells, identification of four complementation groups. Proc. Natl. Acad. Sci. USA, 55: 6042-6046, 1988.
15. Aden, D P., Fogel, A., Plotkin, S., Damjanov, I., and Knowles, B. B Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (Lond ), 282: 615-616, 1979.
16. Lanford, R. E., Carey, K. D., Estlack, L. E., Smith, G C., and Hay, R. V. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell. & Dev. Biol , 25: 174-182, 1989.
17. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
18. Towbin, H , Staebelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76. 4350-4354, 1979.
19. Adams, D J., Watkins, P. J , Knick, V. C., Tuttle, R. L., and Bair, K W. Evaluation of arylmethylaminopropandiols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo. Cancer Res., 50: 3663-3669, 1990.
20. Huber, B E., and Cordingley, M G Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells Oncogene, 3. 245-256, 1988.
21. Cifone, M A. In vitro growth characteristics associated with benign and metastatic variants of tumor cells Cancer Metastasis Rev , 1. 335-347, 1982.
22. Freedman, V H , and Shin, S. Cellular tumorigenicity in nude mice, correlation with cell growth in semi-solid medium. Cell, 3: 355-359, 1974.
23. Andriole, G. L., Mule, J. J , Hasen, C T., Linehan, W. M., and Rosenberg. S. A. Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice. J. Immunol., 135: 2911-2913, 1985.
24. Baker, S. J , Markowitz, S., Fearon, E R., Wilton, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
25. Runnebaum, I. B., Yee, J-K., Kieback, D. G., Sukumar, S., and Friedmann, T. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles. Anticancer Res., 14: 1137-1144, 1994
26. Hamer, D. H. Metallothionein. Annu. Rev. Biochem., 55: 913-951, 1986.